We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Forty Years of Lithium Treatment

Joanna Moncrieff, MBBS
Arch Gen Psychiatry. 1998;55(1):92-93. doi:.
Text Size: A A A
Published online


I was interested by the retrospective by Schou1 on lithium treatment and the accompanying commentaries. However, some important recent developments and debates concerning lithium were not mentioned. Several commentators speculate on the reasons for the discrepancy between the dramatic results of the early placebo-controlled trials of lithium and subsequent comparative trials and naturalistic data. In an article published in 1995,2 I pointed out that a possible explanation for this situation lies in the designs of these early studies. Many of them were discontinuation studies in which patients who had been receiving lithium were allocated to either continue receiving lithium or to have placebo substitution. This type of design cannot address the question of the efficacy of prophylaxis, particularly because of mounting evidence that lithium withdrawal induces manic relapse. Recent reviews on the subject have concluded that there is substantial evidence of a lithium withdrawal–related phenomenon.3,4 It is most surprising that this issue was not addressed in the series of articles in the ARCHIVES, in view of its implications for the use of lithium and its bearing on the evidence for efficacy.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





January 1, 1998
Ross J. Baldessarini, MD; Leonardo Tondo, MD; Adele C. Viguera, MD
Arch Gen Psychiatry. 1998;55(1):93. doi:.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

5 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...